Stay updated on Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a site software/display update rather than a change to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-26T07:55:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated to a newer version.
    Difference
    0.1%
    Check dated 2026-04-19T01:13:01.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Site patch version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:38:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:29:22.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content appears unchanged between versions.
    Difference
    0.1%
    Check dated 2026-02-27T18:58:49.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no changes to page content or functionality; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:54:01.000Z thumbnail image

Stay in the know with updates to Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.